Log | Progress In Mind

Log Type	Authored on	Log Message	Authored by
Newsletter subscribed	Wed, 10/12/2022 - 16:11	Newsletter subscribed - Progress in Mind Australia newsletter	Gäst
Newsletter opened	Wed, 02/02/2022 - 09:03	Opened	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://progress.im/en/newsletter/confirm/remove	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en/content/should-antipsychotic-medications-be-stopped-early-possible-after-first-episode-1	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en/content/personalizing-antipsychotic-therapy-improve-functional-outcomes-and-quality-life-4	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en/content/can-gender-specific-screening-tools-aid-recognition-male-depression-3	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://progress.im/en/newsletter/confirm/remove	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en/content/if-first-you-don%E2%80%99t-succeed-try-another-cgrp-antibody-migraine-prevention-1	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en/content/can-gender-specific-screening-tools-aid-recognition-male-depression-3	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en/content/if-first-you-don%E2%80%99t-succeed-try-another-cgrp-antibody-migraine-prevention-1	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en/content/should-antipsychotic-medications-be-stopped-early-possible-after-first-episode-1	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en	Gäst

Log Type	Authored on	Log Message	Authored by
Newsletter subscribed	Wed, 10/12/2022 - 16:11	Newsletter subscribed - Progress in Mind Australia newsletter	Gäst
Newsletter opened	Wed, 02/02/2022 - 09:03	Opened	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://progress.im/en/newsletter/confirm/remove	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en/content/should-antipsychotic-medications-be-stopped-early-possible-after-first-episode-1	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en/content/personalizing-antipsychotic-therapy-improve-functional-outcomes-and-quality-life-4	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en/content/can-gender-specific-screening-tools-aid-recognition-male-depression-3	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://progress.im/en/newsletter/confirm/remove	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en/content/if-first-you-don%E2%80%99t-succeed-try-another-cgrp-antibody-migraine-prevention-1	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter opened	Wed, 10/12/2022 - 16:11	Opened	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en/content/can-gender-specific-screening-tools-aid-recognition-male-depression-3	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en/content/if-first-you-don%E2%80%99t-succeed-try-another-cgrp-antibody-migraine-prevention-1	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en/content/should-antipsychotic-medications-be-stopped-early-possible-after-first-episode-1	Gäst
Newsletter clicked	Tue, 11/08/2022 - 19:04	Clicked https://belgium-luxembourg.progress.im/en	Gäst

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER